Efficacy of levetiracetam for language dysfunction associated with benign epilepsy with centrotemporal spikes
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Levetiracetam (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 20 Oct 2009 UCB added as trial sponsor as reported by ClinicalTrials.gov.
- 01 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.